ClinicalTrials.gg
RecruitingNCT07228845Updated May 1, 2026

Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing Loss

An interventional study of BTE hearing aids with compatible ear tips (Third-party, FlexResin, Resin) and BTE hearing aids with compatible ear tips (FlexResin, Resin, Third-party, FlexResin) in Hearing Aids, Hearing Loss, Bilateral Sensorineural and 3D Printing, sponsored by University of Arizona. Recruiting at 1 site in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by University of Arizona · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 321 studies in Hearing Loss with a site in United States — 82 open to participants now, 94 under way, 3 of them phase 3. Hearing Loss · United States.

Planned enrollment
172nd of 272
32 · median 48
Started
2026
with 24 others
No phase
212 of 321
54 open now
Primary completion
2027-04
later than 35 of 93 live
Registered
300th of 321
by date

Among the 321 studies in Hearing Loss with a site in United States, this one is the 172nd largest by planned enrollment of the 272 interventional ones that give a count, is one of 25 that started in 2026, is one of 212 with no phase, reaches primary completion later than 35 of the 93 other live ones, and was the 300th registered.

Hearing Loss

797 studies on the registry are indexed under Hearing Loss; 194 are open to participants now.

Browse Hearing Loss studies →

Open to participants now

82 of the 321 studies in Hearing Loss with a site in United States are open now. Recruiting first, the newest first:

76 more — sign in →

All 82 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 125 Hearing Loss studies recruiting now, 60 (48%) set no upper age limit and 43 (34%) stop at 75 or younger; 47 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 89 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 321 studies in Hearing Loss with a site in United States, or all of them as a file.
02

Study summary

Access to affordable and timely hearing healthcare remains a major challenge for many individuals, partly due to the high cost and long turnaround time. This study will explore whether 3D-printed ear tips perform as well as or better than standard ear tips in terms of sound quality, comfort, and fit over a prolonged duration in a sample of individuals with bilateral hearing loss. It will also compare how long each method takes to make and how much each costs.

03

Conditions studied

  • Hearing Aids
  • Hearing Loss, Bilateral Sensorineural
  • 3D Printing

Browse trials for

Keywords

  • hearing aids
  • 3D printing
  • hearing loss
04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Bilateral, symmetric, sensorineural hearing loss, with thresholds between normal and severe degree of hearing loss
  • Normal otoscopy: patent ear canals with normal appearing eardrums and aerated middle ear, bilaterally.
  • English speaking.

Exclusion criteria

Exclusion Criteria:

  • Self reported history of extensive or current outer or middle ear pathology.
  • Self reported history of extensive outer or middle ear surgery.
  • Self reported history of neurological or cognitive disorder.
  • Active ear infection
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    In-house Study group_Resin

    participants will initially receive ear tips fabricated using biocompatible resin

    Device: BTE hearing aids with compatible ear tips (Resin, Third-party, FlexRes)

  • Active comparator
    Third-party Manufactured

    participants will initially receive ear tips fabricated by third party manufacturer using biocompatible resin

    Device: BTE hearing aids with compatible ear tips (Third-party, FlexResin, Resin)

  • Experimental
    In-house Study group_FlexibleResin

    Participants will initially receive ear tips fabricated using biocompatible flexible resin

    Device: BTE hearing aids with compatible ear tips (FlexResin, Resin, Third-party, FlexResin)

Interventions

  • DeviceBTE hearing aids with compatible ear tips (Third-party, FlexResin, Resin)

    Hearing aids will be fit with three different types of customized ear tips. They will wear each ear tip for 1 week. The following order participants will wear each ear tip includes: Third-party, FlexResin, Resin. Hearing aids will be programmed to fit the participants' hearing loss from 250-8000Hz. A short washout period will follow completion of testing with ear tip group.

  • DeviceBTE hearing aids with compatible ear tips (FlexResin, Resin, Third-party, FlexResin)

    Hearing aids will be fit with three different types of customized ear tips. They will wear each ear tip for 1 week. The following order participants will wear each ear tip includes: Resin, Third-party, FlexResin. Hearing aids will be programmed to fit the participants' hearing loss from 250-8000Hz. A short washout period will follow completion of testing with ear tip group

  • DeviceBTE hearing aids with compatible ear tips (Resin, Third-party, FlexRes)

    Hearing aids will be fit with three different types of customized ear tips. They will wear each ear tip for 1 week. The following order participants will wear each ear tip includes: Resin, Third-party, FlexResin. Hearing aids will be programmed to fit the participants' hearing loss from 250-8000Hz. A short washout period will follow completion of testing with ear tip group

06

What researchers measure

Primary outcomes

  1. Outer EAR comfort questionnaire

    A validated questionnaire, Outer EAR, will be used to elicit patient perception of physical comfort, acoustic comfort, quality of voice, and overall self-perceived satisfaction. Includes 6 items (5 levels) , with 5 representing best possible function/rating.

    Time frame: through study completion, an average of 1 week

  2. Real Ear Measures

    Evaluation of ear canal acoustics with participant wearing a hearing aid and eartip type (3d party, in-house\_Resin, in-house\_FlexResin). A thin microphone tube is placed in the ear canal to measure the average amount gain (dB SPL) across various frequencies (250-8000Hz) while the participant sits in front of a speaker playing sound samples. Results are recorded in gain (dB SPL) across frequencies.

    Time frame: through study completion, an average of 1 week

Secondary outcomes

  1. Cost

    The total raw cost ($, dollars US)

    Time frame: through study completion, an average of week

  2. Time

    Time-to-subject for each ear tip type

    Time frame: through study completion, an average of week

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Apr 2027, 13 months after the start.

Of 197 non-industry interventional studies with no phase under Hearing Loss, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 59. This study's planned 13 months is below that.

Counting every sponsor, half of 323 studies reached it within 19 months; a quarter within 5 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2025
First posted
Nov 14, 2025
StartActual
Mar 15, 2026
Primary completionEst.
Apr 15, 2027
CompletionEst.
Apr 25, 2027
Last update
May 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07228845
Responsible party
Bryan Wong (Assistant Professor of Practice, University of Arizona) — Principal investigator
First posted
Nov 14, 2025
Start date
Mar 15, 2026
Primary completion
Apr 15, 2027 (estimated)
Completion
Apr 25, 2027 (estimated)
Last update
May 1, 2026

Study contacts

Bryan Wong, AuD, PhD
Contact
bryanwong@arizona.edu
16025270359 ext. 5206268549

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion